Oncology Vol 29 No 9

September 15, 2015

Although screening methods for HPV-OPSCC have not yet been developed, population-based prevention may be achievable through HPV vaccination, but only if concerted efforts are made to increase vaccine uptake in the United States.

September 15, 2015

Current data challenge the statement that recommendations for postmastectomy radiotherapy should be based on the highest clinical or pathologic stage. Instead, data suggest that in a majority of patients, the pathologic stage after neoadjuvant chemotherapy carries more prognostic value.

September 15, 2015

As technology has affected every segment of society, we in the oncology community have a responsibility to make every effort to utilize these advances to enable the broadest possible outreach to our patient population in a continual process of quality improvement.

September 15, 2015

The evidence suggests that few centers offer IP therapy routinely. Why? The answer may be that oncologists simply don’t know what to do. There have been three completely distinct regimens, none of which has been used in the outpatient setting.

September 15, 2015

Despite the clearly established overall health benefits of exercise, its role in reducing prostate cancer risk is unclear. Whereas some studies found often dramatic reductions in prostate cancer risk, others found no effect.

September 15, 2015

Based on the currently available scientific evidence, HIPEC should not be considered a standard therapeutic option after optimal cytoreduction in advanced ovarian cancer, nor should it be offered outside of a clinical trial.

September 15, 2015

In most cases, localized small-cell bladder cancer requires cystectomy for optimal cure rates.

September 15, 2015

Radiation therapy with concurrent chemotherapy is an effective treatment strategy for small-cell bladder cancer.

September 15, 2015

April 01, 2015

Women with diabetes are at a greater risk of being diagnosed with advanced-stage breast cancer, according to a retrospective study.